Reborna Biosciences
OverviewSuggest Edit
Reborna Biosciences is a company that provides drugs acting on ribonucleic acid (RNA) to patients suffering from rare genetic diseases. It develops drug discovery technology enabling low-molecular compounds to target RNA.
| Type | Private | |
| Founded | 2018 | |
| Website | rebornabiosciences.com |
Latest Updates
| Cybersecurity rating | A | More |
Reborna Biosciences Financials and Metrics
Summary Metrics
Founding Date | 2018 |
Reborna Biosciences Cybersecurity Score
Reborna Biosciences Online and Social Media Presence
Reborna Biosciences's Trends
Reborna Biosciences Frequently Asked Questions
When was Reborna Biosciences founded?
Reborna Biosciences was founded in 2018.
Who are Reborna Biosciences competitors?
Competitors of Reborna Biosciences include Juventas Therapeutics, BioSavita and CRISPR Therapeutics.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies